MedPath

Pizotifen

Generic Name
Pizotifen
Brand Names
Sandomigran
Drug Type
Small Molecule
Chemical Formula
C19H21NS
CAS Number
15574-96-6
Unique Ingredient Identifier
0BY8440V3N
Background

Pizotifen belongs to the class of antamines and is related to cyproheptadine. It is a potent serotonin and tryptamine antagonist that has been used for migraine prevention for many years. It exhibits weak anticholinergic, antihistamine, and antikinin actions in addition to sedative and appetite-stimulating properties . Some patients receiving pizotifen treatment developed tolerance with the prolonged use of the drug . Numerous studies have revealed the potential antidepressant effects of pizotifen, which are independent of its antimigraine action . While it is suggested that pizotifen may act similarly to the classic tricyclic antidepressants , its full mechanism of antidepressant action is not fully elucidated. Pizotifen hydrochloride is an active ingredient in Sandomigran, which is used for the prophylactic management of migraines. Sandomigran is available in a number of countries but is not approved by the FDA nor EMA.

Indication

Indicated for the prophylactic management of migraines .

Associated Conditions
Migraine
Associated Therapies
-

Comparative Efficacy of Escitalopram Monotherapy and Escitalopram in Adjuvant With Pizotifen in Depressive Disorder

Not Applicable
Recruiting
Conditions
Depression
Interventions
First Posted Date
2024-07-15
Last Posted Date
2024-07-15
Lead Sponsor
Riphah International University
Target Recruit Count
88
Registration Number
NCT06500624
Locations
🇵🇰

Riphah International University, Rawalpindi, Punjab, Pakistan

Comparison of Efficacy Between Combination of Amitriptyline-propranolol and Pizotifen for Migraine Prophylaxis.

Phase 2
Active, not recruiting
Conditions
Migraine
Interventions
Drug: Amitriptyline-propranolol
Drug: Pizotifen
First Posted Date
2023-12-06
Last Posted Date
2023-12-06
Lead Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Target Recruit Count
140
Registration Number
NCT06158230
Locations
🇧🇩

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

© Copyright 2025. All Rights Reserved by MedPath